Showing 11 - 20 of 154
There has been long-standing interest in the use of incentives to encourage delivery of high-quality health care services at the lowest feasible cost. Although it is clear that health care professionals have intrinsic incentives to deliver high-quality care to patients, there are significant...
Persistent link: https://www.econbiz.de/10013018136
Objective: To value services that help organisations to manage performance concerns with doctors, dentists or pharmacists. Methods: Qualitative and quantitative methods. Qualitative analysis consists of: a literature review; interviews with support service providers and clinical professional...
Persistent link: https://www.econbiz.de/10013018939
Expenditure on medicines is a readily identifiable element of health service costs. As such, it is the focus of much attention by payers, not least in the UK despite the fact that the ex-manufacturer cost of medicines represents less than 10% of total UK National Health Service (NHS)...
Persistent link: https://www.econbiz.de/10013019275
Objectives: The purpose of this research is to identify the attributes to include in an orphan medicinal product (OMP) value framework, determine their relative importance via a multi-criteria decision analysis (MCDA) process, and test whether an MCDA approach can practically support decision...
Persistent link: https://www.econbiz.de/10013019295
Expenditure on medicines is a readily identifiable element of health service costs. As such, it is the focus of much attention by payers, not least in the UK despite the fact that the ex-manufacturer cost of medicines represents less than 10% of total UK National Health Service (NHS)...
Persistent link: https://www.econbiz.de/10013019358
Persistent link: https://www.econbiz.de/10013017593
Knowing the net value that companies, or whole sectors of the economy, bring is clearly important when considering economic and industrial policy. In this paper we estimate the economic contribution to the UK made by two British based, research intensive, pharmaceutical companies: AstraZeneca...
Persistent link: https://www.econbiz.de/10013017910
The objective of this briefing is to summarise concisely the evidence on incentives that encourage providers of health care to follow guidance on best practice, particularly where that guidance requires the use of specific medicines or other health technologies. We define incentives broadly, to...
Persistent link: https://www.econbiz.de/10012871229
In April 2003 a new payment system for hospitals called Payment by Results (PbR) was introduced in England. The new system is a fixed tariff case-mix based prospective payment system which reimburses hospitals for the type and amount of care they provide. By linking provider income more closely...
Persistent link: https://www.econbiz.de/10014049862
Persistent link: https://www.econbiz.de/10003306100